Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE)

Sierra Leone Trial to Introduce a Vaccine against Ebola

The College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, the Sierra Leone Ministry of Health and Sanitation (MoHS), and the U.S. Centers for Disease Control and Prevention (CDC) are working together on an Ebola vaccine clinical trial in Sierra Leone, which launched in April 2015.

This study, called the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE), is designed to assess the safety and efficacy of a candidate Ebola vaccine rVSV-ZEBOV among health and other frontline workers.

Related Links

illustration of colorful DNA strand behind the text - CDC uses next-generation sequencing to identify hemorrhagic fever viruses in bats

TOP